Anti-hepatoma activity of resveratrol in vitro

被引:38
作者
Sun, ZJ [1 ]
Pan, CE [1 ]
Liu, HS [1 ]
Wang, GJ [1 ]
机构
[1] Xi An Jiao Tong Univ, First Hosp, Dept Hepatobiliary Surg, Xian 710061, Shaanxi Prov, Peoples R China
关键词
D O I
10.3748/wjg.v8.i1.79
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To study the anti-tumor effect of resveratrol alone and the synergistic effects of resveratrol with 5-FU on the growth of H-22 cells line in vitro. Methods. The number of cells was measured by MTT method, the morphological changes of H-22 cells were investigated under microscopy and electron microscopy. Results: Resveratrol inhibited the growth of hepatoma cells line H-22 in a dose- and time-dependent manner. IC50 of the resveratrol on H-22 cells was 6.57mg.L-1. The synergistic antintumor effects of resveratrol with 5-FU increased to a greater extent than for H-22 cells treated with 5-FU alone (70.2% vs 28.4%) (P<0.05). Under microscope and electron microscope, characteristics of apoptosis such as typical apoptotic bodies were commonly found in tumor cells in the drug-treated groups. Conclusion: Resveratrol can suppresses the growth of H-22 cells in vitro, its anti-tumor activity may occur through the induction of apoptosis.
引用
收藏
页码:79 / 81
页数:3
相关论文
共 49 条
[1]   Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells [J].
Bernhard, D ;
Tinhofer, I ;
Tonko, M ;
Hübl, H ;
Ausserlechner, MJ ;
Greil, R ;
Kofler, R ;
Csordas, A .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (09) :834-842
[2]  
Cai WX, 1998, WORLD J GASTROENTERO, V4, P181
[3]   Resveratrol arrests the cell division cycle at S/G2 phase transition [J].
Della Ragione, F ;
Cucciolla, V ;
Borriello, A ;
Della Pietra, V ;
Racioppi, L ;
Soldati, G ;
Manna, C ;
Galletti, P ;
Zappia, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (01) :53-58
[4]  
DENG ZL, 2000, WORLD J GASTROENT S3, V6, P75
[5]  
Dörrie J, 2001, CANCER RES, V61, P4731
[6]  
Fan J, 2001, WORLD J GASTROENTERO, V7, P28
[7]   Resveratrol, a remarkable inhibitor of ribonucleotide reductase [J].
Fontecave, M ;
Lepoivre, M ;
Elleingand, E ;
Gerez, C ;
Guittet, O .
FEBS LETTERS, 1998, 421 (03) :277-279
[8]  
GU GW, 1999, SHIJIE HUAREN XIAOHU, V7, P80
[9]   A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol [J].
Gusman, J ;
Malonne, H ;
Atassi, G .
CARCINOGENESIS, 2001, 22 (08) :1111-1117
[10]   Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway [J].
Huang, CS ;
Ma, WY ;
Goranson, A ;
Dong, ZG .
CARCINOGENESIS, 1999, 20 (02) :237-242